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The title compound, C17H21BrN4OS, was synthesized as a
potential reverse transcriptase (RT) inhibitor of the human
immunodeﬁciency virus type 1 (HIV-1). In the molecule, there
is an N—H   S hydrogen bond making a ﬁve-membered ring.
In the crystal, molecules are connected into centrosymmetric
dimers via pairs of N—H   N and weak C—H   N hydrogen
bonds. The crystal structure also features C—H   O inter-
actions.
Related literature
The 1,2,4-triazole scaffold and its analogues are important
pharmacophores that can be found in biologically active
compounds across a number of different therapeutic areas,
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Table 1
Hydrogen-bond geometry (A ˚ ,  ).
D—H   AD —H H   AD    AD —H   A
N4—H4   S1 0.86 2.61 3.096 (2) 117
N4—H4   N1
i 0.86 2.55 3.339 (3) 153
C1—H1   O1
ii 0.93 2.29 3.214 (3) 171
C13—H13   N1
i 0.93 2.48 3.342 (3) 153
Symmetry codes: (i)  x þ 1; y þ 2; z þ 1; (ii) x;y þ 1;z.
Data collection: SMART (Bruker, 1998); cell reﬁnement: SAINT
(Bruker, 1998); data reduction: SAINT; program(s) used to solve
structure: SHELXS97 (Sheldrick, 2008); program(s) used to reﬁne
structure: SHELXL97 (Sheldrick, 2008); molecular graphics:
SHELXTL (Sheldrick, 2008); software used to prepare material for
publication: SHELXTL.
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N-(4-Bromophenyl)-2-[(1-cyclohexylmethyl-1H-1,2,4-triazol-3-
yl)sulfanyl]acetamide
Yue-Ping Wang, Wan-Lu Yan, Qiong Guo and Yan-Ping He
Comment 
The 1,2,4-triazole scaffold and its analogues are important pharmacophores that can be found in biologically active 
compounds across a number of different therapeutic areas; these include antifungal (Tafi, et al., 2002), antibacterial (Sui, 
et al., 1998), antiasthmatic (Naito, et al., 1996) and anticancer activities (Lin, et al., 2005), etc. In the course of our search 
for new anti-HIV-1 agents, we have synthesized a new series of 1,2,4-triazole analogues, including the title compound, 
(I), as potential HIV-1 inhibitors.
The chemical structure of (I) is shown in Fig.1. The molecule is stabilized by a weak intramolecular N4—H4···S1 
hydrogen bond (Table 1). The cyclohexyl ring adopts the lowest energy chair conformation. The torsion angle (C1—N3
—C2—C3), which describes the arrangement between the cyclohexyl ring and the triazole moiety, is -112.1 (3) °; the 
torsion angle C12—N4—C11—O1, which characterizes the location of the CONH2 group relative to the phenyl ring, is 
3.5 (4) °.
In the crystal structure, centrosymmetric dimmers are formed by pairs of N4—H4···N1i and C13—H13···N1i hydrogen 
bonds [symmetry code: (i) -x + 1, -y + 2,-z + 1]. These dimmers are further linked into chains by weak C—H···O 
interactions (Table 1, Fig.2).
Experimental 
To a stirred solution of 2-((1H-1,2,4-triazol-3-yl)thio)-N-(4-bromophenyl)acetamide (3.12 g, 10 mmol) in anhydrous 
EtOH (75 ml) was added K2CO3 (1.38 g, 0.01 mol) under a nitrogen atmosphere. The mixture was stirred at 298 K for 15 
min, then (bromomethyl)cyclohexane (0.53 g, 0.03 mol) was added, and the reaction mixture was refluxed for 8 h under a 
nitrogen atmosphere. The reaction mixture was poured into cold H2O (80 ml), then the aqueous phase was extracted with 
EtOAc (3×50 ml). The combined organic layer was washed with H2O (3×50 ml), dried (Mg2SO4), filtered and 
concentrated in vacuo to give the crude product, which was purified by chromatography (eluent EtOAc/PE 100:25) to 
afford the title compound (yield: 23%; m.p. 398.7–398.9 K). Single crystals of (I) suitable for X-ray diffraction were 
grown from a solution in EtOAc by slow evaporation. The product was characterized by IR, MS, 1H NMR and 13C NMR.
Refinement 
All H atoms were placed in calculated positions with N—H = 0.86 Å and C—H = 0.93–0.98 Å, and with Uiso(H) = 
1.2Ueq(C, N).
Computing details 
Data collection: SMART (Bruker, 1998); cell refinement: SAINT (Bruker, 1998); data reduction: SAINT (Bruker, 1998); 
program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 supplementary materials
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(Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: 
SHELXTL (Sheldrick, 2008).
Figure 1
The molecular structure of the title compound, showing the atom labeling scheme and 30% probability displacement 
ellipsoids. supplementary materials
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Figure 2
The crystal packing of the title compound, viewed along the a axis. Intermolecular N—H···Ni, C—H···Ni, C—H···Oii 






Hall symbol: -P 1
a = 7.2061 (8) Å
b = 9.521 (1) Å
c = 14.2862 (16) Å
α = 104.132 (1)°
β = 90.804 (1)°
γ = 95.820 (1)°
V = 944.84 (18) Å3
Z = 2
F(000) = 420
Dx = 1.439 Mg m−3
Melting point: 398.8(1) K
Mo Kα radiation, λ = 0.71073 Å
Cell parameters from 2212 reflections
θ = 2.3–24.5°supplementary materials
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µ = 2.30 mm−1
T = 298 K
Block, colourless
0.25 × 0.16 × 0.12 mm
Data collection 
Bruker SMART CCD area-detector 
diffractometer
Radiation source: fine-focus sealed tube
Graphite monochromator
phi and ω scans
Absorption correction: multi-scan 
(SADABS; Bruker, 1998)
Tmin = 0.597, Tmax = 0.770
8793 measured reflections
4076 independent reflections
2644 reflections with I > 2σ(I)
Rint = 0.025













Primary atom site location: structure-invariant 
direct methods
Secondary atom site location: difference Fourier 
map




2) + (0.0382P)2 + 0.1448P] 




Δρmax = 0.34 e Å−3
Δρmin = −0.42 e Å−3
Special details 
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full 
covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and 
torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. 
An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, 
conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used 
only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 
are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
xyz U iso*/Ueq
Br1 1.07267 (5) 0.57798 (4) 0.86425 (2) 0.07787 (16)
N1 0.2679 (3) 1.0737 (2) 0.49703 (17) 0.0506 (6)
N2 0.1739 (3) 0.9382 (2) 0.60131 (15) 0.0444 (5)
N3 0.1580 (3) 1.0832 (2) 0.64012 (16) 0.0461 (5)
N4 0.4730 (3) 0.6839 (2) 0.59376 (15) 0.0434 (5)
H4 0.5020 0.7572 0.5696 0.052*
O1 0.2434 (3) 0.5032 (2) 0.59473 (15) 0.0683 (6)
S1 0.28308 (9) 0.78377 (7) 0.42896 (5) 0.04868 (18)
C1 0.2140 (4) 1.1586 (3) 0.5772 (2) 0.0532 (7)
H1 0.2151 1.2590 0.5881 0.064*
C2 0.0908 (4) 1.1312 (3) 0.7364 (2) 0.0557 (7)
H2A −0.0288 1.0766 0.7404 0.067*
H2B 0.0714 1.2333 0.7483 0.067*
C3 0.2247 (4) 1.1117 (3) 0.81422 (19) 0.0537 (7)supplementary materials
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H3 0.2486 1.0092 0.7988 0.064*
C4 0.4098 (4) 1.2034 (4) 0.8179 (2) 0.0726 (9)
H4A 0.3883 1.3049 0.8277 0.087*
H4B 0.4685 1.1743 0.7565 0.087*
C5 0.5408 (5) 1.1879 (5) 0.8986 (3) 0.0958 (12)
H5A 0.5750 1.0892 0.8847 0.115*
H5B 0.6540 1.2537 0.9016 0.115*
C6 0.4501 (7) 1.2220 (5) 0.9949 (3) 0.1066 (14)
H6A 0.5329 1.2047 1.0440 0.128*
H6B 0.4294 1.3241 1.0124 0.128*
C7 0.2675 (6) 1.1298 (5) 0.9914 (2) 0.0935 (12)
H7A 0.2096 1.1578 1.0531 0.112*
H7B 0.2901 1.0285 0.9808 0.112*
C8 0.1356 (5) 1.1455 (4) 0.9123 (2) 0.0755 (9)
H8A 0.1012 1.2442 0.9268 0.091*
H8B 0.0227 1.0797 0.9098 0.091*
C9 0.2392 (3) 0.9403 (3) 0.51580 (18) 0.0405 (6)
C10 0.1917 (4) 0.6457 (3) 0.48677 (19) 0.0465 (6)
H10A 0.0761 0.6752 0.5154 0.056*
H10B 0.1590 0.5573 0.4363 0.056*
C11 0.3064 (4) 0.6054 (3) 0.56361 (19) 0.0435 (6)
C12 0.6046 (3) 0.6588 (2) 0.66041 (17) 0.0397 (6)
C13 0.7805 (3) 0.7356 (3) 0.66796 (18) 0.0449 (6)
H13 0.8052 0.8042 0.6320 0.054*
C14 0.9196 (4) 0.7118 (3) 0.72794 (19) 0.0494 (6)
H14 1.0376 0.7631 0.7319 0.059*
C15 0.8817 (4) 0.6118 (3) 0.78159 (18) 0.0487 (6)
C16 0.7086 (4) 0.5367 (3) 0.7767 (2) 0.0575 (7)
H16 0.6845 0.4700 0.8141 0.069*
C17 0.5691 (4) 0.5594 (3) 0.71644 (19) 0.0548 (7)
H17 0.4513 0.5082 0.7134 0.066*
Atomic displacement parameters (Å2) 
U11 U22 U33 U12 U13 U23
Br1 0.0771 (3) 0.0900 (3) 0.0738 (2) 0.01971 (19) −0.02021 (18) 0.03131 (19)
N1 0.0502 (13) 0.0471 (13) 0.0616 (15) −0.0016 (11) −0.0049 (11) 0.0299 (12)
N2 0.0453 (12) 0.0378 (12) 0.0519 (13) 0.0023 (10) −0.0001 (10) 0.0156 (10)
N3 0.0460 (13) 0.0382 (12) 0.0539 (14) 0.0033 (10) −0.0043 (10) 0.0119 (10)
N4 0.0402 (12) 0.0394 (11) 0.0550 (13) 0.0011 (10) −0.0018 (10) 0.0217 (10)
O1 0.0601 (13) 0.0535 (12) 0.0978 (16) −0.0140 (10) −0.0139 (11) 0.0406 (12)
S1 0.0452 (4) 0.0554 (4) 0.0474 (4) 0.0041 (3) 0.0001 (3) 0.0172 (3)
C1 0.0509 (16) 0.0387 (15) 0.074 (2) 0.0001 (13) −0.0130 (15) 0.0247 (15)
C2 0.0510 (17) 0.0502 (16) 0.0640 (19) 0.0086 (13) 0.0011 (14) 0.0091 (14)
C3 0.0556 (17) 0.0485 (16) 0.0580 (17) 0.0070 (13) 0.0034 (14) 0.0145 (13)
C4 0.060 (2) 0.087 (2) 0.074 (2) −0.0060 (18) −0.0076 (16) 0.0336 (18)
C5 0.070 (2) 0.128 (3) 0.098 (3) −0.007 (2) −0.025 (2) 0.051 (3)
C6 0.123 (4) 0.119 (3) 0.076 (3) 0.001 (3) −0.031 (3) 0.026 (2)
C7 0.126 (4) 0.105 (3) 0.056 (2) 0.026 (3) 0.008 (2) 0.027 (2)
C8 0.083 (2) 0.078 (2) 0.066 (2) 0.0134 (19) 0.0163 (19) 0.0176 (18)supplementary materials
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C9 0.0322 (13) 0.0427 (14) 0.0492 (15) −0.0013 (11) −0.0073 (11) 0.0191 (12)
C10 0.0425 (15) 0.0378 (14) 0.0566 (16) −0.0001 (11) −0.0033 (12) 0.0087 (12)
C11 0.0409 (15) 0.0342 (13) 0.0544 (16) 0.0046 (11) 0.0007 (12) 0.0086 (12)
C12 0.0415 (14) 0.0355 (13) 0.0446 (14) 0.0055 (11) 0.0020 (11) 0.0141 (11)
C13 0.0465 (15) 0.0410 (14) 0.0498 (15) −0.0022 (12) −0.0011 (12) 0.0192 (12)
C14 0.0428 (15) 0.0464 (15) 0.0581 (17) −0.0043 (12) −0.0051 (13) 0.0153 (13)
C15 0.0555 (17) 0.0498 (16) 0.0436 (15) 0.0113 (14) −0.0053 (12) 0.0149 (12)
C16 0.0617 (19) 0.0613 (18) 0.0582 (18) −0.0004 (15) 0.0003 (15) 0.0343 (15)
C17 0.0482 (16) 0.0591 (17) 0.0623 (18) −0.0054 (14) 0.0002 (14) 0.0298 (15)
Geometric parameters (Å, º) 
Br1—C15 1.903 (2) C5—H5A 0.9700
N1—C1 1.319 (3) C5—H5B 0.9700
N1—C9 1.357 (3) C6—C7 1.499 (5)
N2—C9 1.319 (3) C6—H6A 0.9700
N2—N3 1.373 (3) C6—H6B 0.9700
N3—C1 1.324 (3) C7—C8 1.512 (5)
N3—C2 1.447 (3) C7—H7A 0.9700
N4—C11 1.353 (3) C7—H7B 0.9700
N4—C12 1.412 (3) C8—H8A 0.9700
N4—H4 0.8600 C8—H8B 0.9700
O1—C11 1.215 (3) C10—C11 1.510 (3)
S1—C9 1.750 (3) C10—H10A 0.9700
S1—C10 1.793 (3) C10—H10B 0.9700
C1—H1 0.9300 C12—C13 1.387 (3)
C2—C3 1.519 (4) C12—C17 1.388 (3)
C2—H2A 0.9700 C13—C14 1.381 (3)
C2—H2B 0.9700 C13—H13 0.9300
C3—C4 1.512 (4) C14—C15 1.371 (4)
C3—C8 1.525 (4) C14—H14 0.9300
C3—H3 0.9800 C15—C16 1.365 (4)
C4—C5 1.525 (4) C16—C17 1.382 (4)
C4—H4A 0.9700 C16—H16 0.9300
C4—H4B 0.9700 C17—H17 0.9300
C5—C6 1.508 (5)
C1—N1—C9 101.8 (2) C6—C7—C8 112.0 (3)
C9—N2—N3 101.66 (19) C6—C7—H7A 109.2
C1—N3—N2 109.2 (2) C8—C7—H7A 109.2
C1—N3—C2 130.5 (2) C6—C7—H7B 109.2
N2—N3—C2 120.3 (2) C8—C7—H7B 109.2
C11—N4—C12 127.3 (2) H7A—C7—H7B 107.9
C11—N4—H4 116.4 C7—C8—C3 111.3 (3)
C12—N4—H4 116.4 C7—C8—H8A 109.4
C9—S1—C10 100.22 (12) C3—C8—H8A 109.4
N1—C1—N3 111.7 (2) C7—C8—H8B 109.4
N1—C1—H1 124.1 C3—C8—H8B 109.4
N3—C1—H1 124.1 H8A—C8—H8B 108.0
N3—C2—C3 112.8 (2) N2—C9—N1 115.6 (2)supplementary materials
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N3—C2—H2A 109.0 N2—C9—S1 123.67 (18)
C3—C2—H2A 109.0 N1—C9—S1 120.7 (2)
N3—C2—H2B 109.0 C11—C10—S1 120.69 (18)
C3—C2—H2B 109.0 C11—C10—H10A 107.2
H2A—C2—H2B 107.8 S1—C10—H10A 107.2
C4—C3—C2 112.2 (2) C11—C10—H10B 107.2
C4—C3—C8 110.8 (3) S1—C10—H10B 107.2
C2—C3—C8 110.2 (2) H10A—C10—H10B 106.8
C4—C3—H3 107.8 O1—C11—N4 123.6 (2)
C2—C3—H3 107.8 O1—C11—C10 117.7 (2)
C8—C3—H3 107.8 N4—C11—C10 118.6 (2)
C3—C4—C5 111.9 (3) C13—C12—C17 118.6 (2)
C3—C4—H4A 109.2 C13—C12—N4 117.6 (2)
C5—C4—H4A 109.2 C17—C12—N4 123.8 (2)
C3—C4—H4B 109.2 C14—C13—C12 121.1 (2)
C5—C4—H4B 109.2 C14—C13—H13 119.5
H4A—C4—H4B 107.9 C12—C13—H13 119.5
C6—C5—C4 111.2 (3) C15—C14—C13 119.2 (2)
C6—C5—H5A 109.4 C15—C14—H14 120.4
C4—C5—H5A 109.4 C13—C14—H14 120.4
C6—C5—H5B 109.4 C16—C15—C14 120.8 (2)
C4—C5—H5B 109.4 C16—C15—Br1 119.7 (2)
H5A—C5—H5B 108.0 C14—C15—Br1 119.5 (2)
C7—C6—C5 111.2 (3) C15—C16—C17 120.3 (2)
C7—C6—H6A 109.4 C15—C16—H16 119.9
C5—C6—H6A 109.4 C17—C16—H16 119.9
C7—C6—H6B 109.4 C16—C17—C12 120.0 (3)
C5—C6—H6B 109.4 C16—C17—H17 120.0
H6A—C6—H6B 108.0 C12—C17—H17 120.0
C9—N2—N3—C1 −0.3 (3) C1—N1—C9—S1 178.04 (18)
C9—N2—N3—C2 −179.5 (2) C10—S1—C9—N2 6.0 (2)
C9—N1—C1—N3 0.4 (3) C10—S1—C9—N1 −172.49 (19)
N2—N3—C1—N1 −0.1 (3) C9—S1—C10—C11 −81.3 (2)
C2—N3—C1—N1 179.1 (2) C12—N4—C11—O1 3.5 (4)
C1—N3—C2—C3 −112.1 (3) C12—N4—C11—C10 −176.2 (2)
N2—N3—C2—C3 67.0 (3) S1—C10—C11—O1 −174.2 (2)
N3—C2—C3—C4 63.3 (3) S1—C10—C11—N4 5.5 (3)
N3—C2—C3—C8 −172.7 (2) C11—N4—C12—C13 168.5 (2)
C2—C3—C4—C5 177.8 (3) C11—N4—C12—C17 −9.8 (4)
C8—C3—C4—C5 54.1 (4) C17—C12—C13—C14 1.6 (4)
C3—C4—C5—C6 −54.9 (4) N4—C12—C13—C14 −176.8 (2)
C4—C5—C6—C7 55.1 (5) C12—C13—C14—C15 −0.8 (4)
C5—C6—C7—C8 −55.9 (5) C13—C14—C15—C16 −0.4 (4)
C6—C7—C8—C3 55.4 (4) C13—C14—C15—Br1 179.86 (19)
C4—C3—C8—C7 −54.1 (4) C14—C15—C16—C17 0.7 (4)
C2—C3—C8—C7 −178.8 (3) Br1—C15—C16—C17 −179.5 (2)
N3—N2—C9—N1 0.5 (3) C15—C16—C17—C12 0.1 (4)
N3—N2—C9—S1 −178.05 (16) C13—C12—C17—C16 −1.3 (4)supplementary materials
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C1—N1—C9—N2 −0.6 (3) N4—C12—C17—C16 177.0 (2)
Hydrogen-bond geometry (Å, º) 
D—H···AD —H H···AD ···AD —H···A
N4—H4···S1 0.86 2.61 3.096 (2) 117
N4—H4···N1i 0.86 2.55 3.339 (3) 153
C1—H1···O1ii 0.93 2.29 3.214 (3) 171
C13—H13···N1i 0.93 2.48 3.342 (3) 153
Symmetry codes: (i) −x+1, −y+2, −z+1; (ii) x, y+1, z.